Mark A. Demitrack Neuronetics Inc. Biography Publications Institution JoVE Articles Mark A. Demitrack has not added a biography. If you are Mark A. Demitrack and would like to personalize this page please email our Author Liaison for assistance. Publications Durability of Clinical Benefit with Transcranial Magnetic Stimulation (TMS) in the Treatment of Pharmacoresistant Major Depression: Assessment of Relapse During a 6-month, Multisite, Open-label Study Brain Stimulation. Oct, 2010 | Pubmed ID: 20965447 Reply Regarding "efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: a Multisite Randomized Controlled Trial" Biological Psychiatry. Jan, 2010 | Pubmed ID: 19914602 Clinical Significance of Transcranial Magnetic Stimulation (TMS) in the Treatment of Pharmacoresistant Depression: Synthesis of Recent Data Psychopharmacology Bulletin. 2009 | Pubmed ID: 19629020 Cost-effectiveness of Transcranial Magnetic Stimulation in the Treatment of Major Depression: a Health Economics Analysis Advances in Therapy. Mar, 2009 | Pubmed ID: 19330495 Transcranial Magnetic Stimulation in the Acute Treatment of Major Depressive Disorder: Clinical Response in an Open-label Extension Trial The Journal of Clinical Psychiatry. Mar, 2008 | Pubmed ID: 18294022 Transcranial Magnetic Stimulation in the Treatment of Major Depressive Disorder: a Comprehensive Summary of Safety Experience from Acute Exposure, Extended Exposure, and During Reintroduction Treatment The Journal of Clinical Psychiatry. Feb, 2008 | Pubmed ID: 18232722 Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: a Multisite Randomized Controlled Trial Biological Psychiatry. Dec, 2007 | Pubmed ID: 17573044 Clinical Methodology and Its Implications for the Study of Therapeutic Interventions for Chronic Fatigue Syndrome: a Commentary Pharmacogenomics. Apr, 2006 | Pubmed ID: 16610962 Duloxetine in the Acute and Long-term Treatment of Major Depressive Disorder: a Placebo- and Paroxetine-controlled Trial European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. Dec, 2004 | Pubmed ID: 15589385 Duloxetine in the Treatment of Depression: a Double-blind Placebo-controlled Comparison with Paroxetine Journal of Clinical Psychopharmacology. Aug, 2004 | Pubmed ID: 15232330 Basal Circadian and Pulsatile ACTH and Cortisol Secretion in Patients with Fibromyalgia And/or Chronic Fatigue Syndrome Brain, Behavior, and Immunity. Jul, 2004 | Pubmed ID: 15157948 Effects of Duloxetine on Painful Physical Symptoms Associated with Depression Psychosomatics. Jan-Feb, 2004 | Pubmed ID: 14709757 Can Monoamine-based Therapies Be Improved? The Journal of Clinical Psychiatry. 2002 | Pubmed ID: 15453009 Duloxetine 60 Mg Once Daily Dosing Versus Placebo in the Acute Treatment of Major Depression Journal of Psychiatric Research. Nov-Dec, 2002 | Pubmed ID: 12393307 Duloxetine, 60 Mg Once Daily, for Major Depressive Disorder: a Randomized Double-blind Placebo-controlled Trial The Journal of Clinical Psychiatry. Apr, 2002 | Pubmed ID: 12000204 The Tyramine Pressor Test May Have Limited Sensitivity, Especially in the Presence of Dual Serotonin/norepinephrine Uptake Inhibition Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. May, 2002 | Pubmed ID: 11927196 Duloxetine in the Treatment of Major Depressive Disorder: a Double-blind Clinical Trial The Journal of Clinical Psychiatry. Mar, 2002 | Pubmed ID: 11926722 The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression Jared C. Horvath1, John Mathews2, Mark A. Demitrack2, Alvaro Pascual-Leone1 1Berenson-Allen Center for Noninvasive Brain Stimulation, Beth Israel Deaconess Medical Center, 2Neuronetics, Inc. JoVE 2345 Neuroscience
The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression Jared C. Horvath1, John Mathews2, Mark A. Demitrack2, Alvaro Pascual-Leone1 1Berenson-Allen Center for Noninvasive Brain Stimulation, Beth Israel Deaconess Medical Center, 2Neuronetics, Inc. JoVE 2345 Neuroscience